Alkermes Plc (ALKS)
43.63
-0.55
(-1.24%)
USD |
NASDAQ |
Oct 23, 16:00
43.61
-0.02
(-0.05%)
After-Hours: 20:00
Alkermes Market Cap : 7.310B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.310B |
| October 22, 2026 | 7.402B |
| October 21, 2026 | 7.285B |
| October 20, 2026 | 7.390B |
| October 19, 2026 | 7.199B |
| October 16, 2026 | 6.906B |
| October 15, 2026 | 6.718B |
| October 14, 2026 | 6.548B |
| October 13, 2026 | 6.656B |
| October 12, 2026 | 6.745B |
| October 09, 2026 | 6.804B |
| October 08, 2026 | 6.720B |
| October 07, 2026 | 6.944B |
| October 06, 2026 | 6.978B |
| October 05, 2026 | 7.164B |
| October 02, 2026 | 6.995B |
| October 01, 2026 | 6.792B |
| September 30, 2026 | 6.789B |
| September 29, 2026 | 6.836B |
| September 28, 2026 | 6.727B |
| September 25, 2026 | 6.844B |
| September 24, 2026 | 6.834B |
| September 23, 2026 | 7.059B |
| September 22, 2026 | 7.253B |
| September 21, 2026 | 7.402B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.270B |
| September 17, 2026 | 7.826B |
| September 16, 2026 | 7.719B |
| September 15, 2026 | 7.712B |
| September 14, 2026 | 7.678B |
| September 11, 2026 | 7.702B |
| September 10, 2026 | 7.725B |
| September 09, 2026 | 7.606B |
| September 08, 2026 | 7.621B |
| September 04, 2026 | 7.724B |
| September 03, 2026 | 7.854B |
| September 02, 2026 | 7.995B |
| September 01, 2026 | 7.908B |
| August 31, 2026 | 7.873B |
| August 28, 2026 | 7.943B |
| August 27, 2026 | 8.193B |
| August 26, 2026 | 8.236B |
| August 25, 2026 | 8.245B |
| August 24, 2026 | 8.188B |
| August 21, 2026 | 8.097B |
| August 20, 2026 | 8.045B |
| August 19, 2026 | 8.407B |
| August 18, 2026 | 8.290B |
| August 17, 2026 | 8.352B |
| August 14, 2026 | 8.220B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 247.62M |
| Prothena Corp. Plc | 424.30M |
| Incyte Corp. | 23.26B |
| Cue Biopharma, Inc. | 97.58M |
| ADC Therapeutics SA | 183.51M |
Market Cap Related Metrics
| PE Ratio | 113.32 |
| PS Ratio | 4.433 |
| Price to Book Value | 4.042 |
| Price to Free Cash Flow | 33.35 |
| Price | 43.63 |
| Earnings Yield | 0.88% |
| Operating PE Ratio | 51.45 |
| Normalized PE Ratio | 88.75 |